Bell Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.41K | Sell |
61
-10
| -14% | -$395 | ﹤0.01% | 1299 |
|
2025
Q1 | $2.14K | Hold |
71
| – | – | ﹤0.01% | 1287 |
|
2024
Q4 | $2.48K | Hold |
71
| – | – | ﹤0.01% | 1240 |
|
2024
Q3 | $2.85K | Hold |
71
| – | – | ﹤0.01% | 1208 |
|
2024
Q2 | $3.38K | Hold |
71
| – | – | ﹤0.01% | 1115 |
|
2024
Q1 | $3.08K | Hold |
71
| – | – | ﹤0.01% | 1156 |
|
2023
Q4 | $3.59K | Hold |
71
| – | – | ﹤0.01% | 1059 |
|
2023
Q3 | $3.22K | Sell |
71
-31
| -30% | -$1.41K | ﹤0.01% | 1045 |
|
2023
Q2 | $4.19K | Hold |
102
| – | – | ﹤0.01% | 912 |
|
2023
Q1 | $3.65K | Hold |
102
| – | – | ﹤0.01% | 946 |
|
2022
Q4 | $3.85K | Sell |
102
-12
| -11% | -$453 | ﹤0.01% | 945 |
|
2022
Q3 | $5K | Buy |
114
+12
| +12% | +$526 | ﹤0.01% | 686 |
|
2022
Q2 | $4K | Buy |
+102
| New | +$4K | ﹤0.01% | 806 |
|
2021
Q4 | $3K | Buy |
102
+92
| +920% | +$2.71K | ﹤0.01% | 982 |
|
2021
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1774 |
|